1. USING ECONOMIC EVALUATIONS IN DRUG REIMBURSEMENT DECISIONS ‘NICE’ experiences from overseas Michael Drummond Centre for Health Economics University of York United…

Slide 1Prof. Dr. Dr. h.c. Fried Oelschlegel Director of Business Development The Ballast of structures – Lean Management as a prerequisite for global growth in Healthcare…

Slide 1Presenter instructions Do not delete this slide This presentation contains interactive hyperlinks. There are hyperlinks to allow you to view the treatment options…

Slide 1Long Term Conditions Commissioning Plans Dr Adrian Mairs LTCANI Meeting 13 th August 2012 Dr Adrian Mairs LTCANI Meeting 13 th August 2012 Slide 2 LTC Service Team…

Slide 1#HCS2012 Quality and Innovation and the Healthcare Science Connection Melanie Ogden, Associate Director Quality & Innovation, NHS North of England Slide 2 Healthier…

1. A vision for Cheshire and Mersey CLRN Dr Liz Mear, CEO| The Walton Neurological Centre, Liverpool 2. North West Coast AHSN www.nwcahsn.nhs.uk Dr Liz Mear CEO, The Walton…

1. Presenter instructions Do not delete this slide This presentation contains interactive hyperlinks. There are hyperlinks to allow you to view the treatment options for…

1. The Vision for the WessexAHSNMartin Stephens, Interim Managing Director | Wessex AHSN 2. An introductionMartin StephensMay 2013 3. An IntroductionAgenda• Our network•…

Slide 1 NICE and biosimilars 4 March 2015 Paul Chrisp Programme Director, NICE Medicines and Prescribing Centre Slide 2 Outline NICE position on biosimilars Why we revised…

Naltrexone for heroin addiction - oral, depot and implant: behavioral and physical technologies to improve benefit John Strang & John Marsden National Addiction Centre,…